ROPHIBIO

ROPHIBIO is a company developing protein/antibody, gene/cell, and stem cell therapeutics. It offers treatments for lung cancer, neuroblastoma chemotherapy, rheumatis arthritis, autoimmune inner ear disease, and autoimmune Sjogren’s syndrome. The company also provides biosimilar drug candidates, technological services, as well as stem-cell based cosmetics.